CORE
🇺🇦
make metadata, not war
Services
Services overview
Explore all CORE services
Access to raw data
API
Dataset
FastSync
Content discovery
Recommender
Discovery
OAI identifiers
OAI Resolver
Managing content
Dashboard
Bespoke contracts
Consultancy services
Support us
Support us
Membership
Sponsorship
Community governance
Advisory Board
Board of supporters
Research network
About
About us
Our mission
Team
Blog
FAQs
Contact us
Low-dose oral contraceptive to re-induce menstrual bleeding in amenorrheic women on DMPA treatment: A randomized clinical trial
Authors
L. Amanati
S. Arshi
+4 more
H. Eftekhar
F. Ehdaeivand
H. Sadeghi-Bazargani
H. Sezavar
Publication date
1 January 2006
Publisher
Abstract
Background: Depot medroxyprogesterone acetate (DMPA), a long-acting contraceptive, has many advantages over other hormonal contraceptives. However, its major discontinuance reason is bleeding disorders. Our aim was to study bleeding complications of DMPA when used as a contraceptive in the Ardabil district and a clinical trial of low-dose oral contraceptive (LD-OC) pills in controlling these complications. Material/Methods: All 917 women referred to Ardabil's health centers to have a DMPA injection for the first time were entered into a longitudinal study. Those complaining of menstrual cessation were entered into a double-blinded randomized clinical trial. Data were collected by means of nine questionnaires, seven of which were used for descriptive purposes and two for clinical trial study. The data were analyzed with the SPSS statistical package. Results: Those DMPA users with a cesarean section history had a higher chance of bleeding complications. Four hundred forty-four of the 917 women receiving the injection discontinued using it before the end of the study period. The main reason for discontinuation (in 70) was irregular menstrual bleedings and menstrual cessation. In the clinical trial of women with bleeding cessation, 70 of those receiving the LD-OC pill experienced menstrual bleedings again, compared with only 22.7 in the placebo group. The discontinuation rate in the drug group was lower than in the placebo group as well (p<0.05). Conclusions: Treating the menstrual cessation caused by DMPA with LD-OC improves the bleeding pattern and decreases the discontinuation rate. © Med Sci Monit, 2006
Similar works
Full text
Available Versions
eprints Iran University of Medical Sciences
See this paper in CORE
Go to the repository landing page
Download from data provider
oai:eprints.iums.ac.ir:11947
Last time updated on 13/08/2020